Chest Drainage System Market Analysis by Pleural Drainage Systems and Pleural Drainage System Kits, 2023 to 2033. Analyzing Emerging Trends and Opportunities for Chest Drainage Systems Manufacturers in the Backdrop of Rising Integration of Smart Technology in Medical Devices Globally. By 2033, the global chest drainage system market will reach US$ 1,795.93 million.
NEWARK, Del., Oct. 16, 2023 /PRNewswire/ — The global chest drainage system market value is expected to total US$ 1,034.25 million in 2023 and US$ 1,795.93 million by 2033. Demand for chest drainage systems is anticipated to increase at a CAGR of 5.7% during the assessment period.
Book the Sample PDF Summary of the Comprehensive Research Report to learn more: https://www.futuremarketinsights.com/reports/sample/rep-gb-7121
Chest Drainage Systems: A Crucial Tool for Managing Cardiovascular Diseases, Pleural Effusion, and Cancer
Several factors are expected to drive growth in the chest drainage system market during the forecast period. These include the rising prevalence of cardiovascular and respiratory diseases, expanding healthcare infrastructure, increasing number of surgeries, and growing adoption of digital chest drainage systems.
Chest drainage systems are witnessing high demand due to increased chest drainage management usage. These medical devices are widely used to remove fluid, air, or blood from the pleural space. Chest drainage systems treat medical conditions like pleural effusion, hemothorax, and spontaneous pneumothorax. Hence, the rising incidence of these diseases is expected to drive chest drainage system demand during the forecast period.
The prevalence of pleural effusion cases is on the rise for several reasons. First, the aging population is more susceptible to chronic illnesses, including congestive heart failure, a common contributor to pleural effusion. Second, cardiovascular diseases, such as congestive heart failure, continue to rise, often leading to pleural effusion as a complication.
The interconnectedness between cardiovascular diseases and pleural effusion underscores the crucial role of chest drainage systems in managing these conditions. Driven by this, sales of chest drainage systems are expected to thrive steadily through 2033. In the United States, around 1.5 million patients experience pleural effusion yearly, with underlying causes of congestive heart failure, pneumonia, and cancer. This is expected to uplift demand for chest drainage systems as they are often employed for treating pleural effusion.
The increasing incidence of cancer contributes significantly to the demand for chest drainage systems. Pleural effusion can occur due to the tumor or cancer treatments, including radiation therapy and chemotherapy. As cancer diagnoses become more frequent and oncological treatments become more prevalent, the demand for effective pleural effusion management, including chest drainage systems, will rise substantially.
Another key factor boosting the global chest drainage system market is the rising popularity of digitalized chest drainage systems. Digital chest drainage systems are gaining immense traction, allowing medical professionals to monitor patients’ drainage levels and adjust the system setting remotely.
Key Takeaways from the Report
- The global chest drainage system industry is expected to total US$ 1,034.25 million by 2033.
- By product, the pleural drainage systems segment will hold over 82.4% value share by 2033.
- By indication, the pleural effusion segment is set to thrive at 4.5% CAGR through 2033.
- By end user, hospitals segment is expected to attain a valuation of US$ 757.93 million by 2033.
- Sales in the United States are projected to total US$ 478.19 million by 2033.
- Demand in Japan is expected to rise at 9.7% CAGR through 2033.
- India is poised to exhibit a CAGR of 7.1% during the forecast period.
- Total revenue in China is predicted to reach US$ 189.49 million by 2033.
“Rising prevalence of pleural diseases and technological advancement in chest drainage systems are expected to create lucrative growth opportunities for chest drainage system manufacturers over the forecast period,” – says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Top Chest Drainage Systems Manufacturers and their Winning Strategies:
Expansion and acquisition are key strategies of leading manufacturers like Teleflex Incorporated and B. Braun Melsungen AG to enhance their presence globally and compete with other competitors. Following are a few examples of expansion and acquisition made by them to be at the top position:
- In April 2023, Teleflex Incorporated started construction on an expansion project for their Teleflex Medical OEM facility in Jaffrey, NH.
Get a comprehensive view of market competition – Buy the report today and access benchmarking analysis of top players: https://www.futuremarketinsights.com/checkout/7121
Want More Insights?
Future Market Insights (FMI) brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and analyzes the latest industry trends in each sub-segment from 2017 to 2033. The global chest drainage systems market is segmented in detail to cover every aspect of the business and present a complete intelligence approach to the reader.
The study provides compelling insights into chest drainage system market segments, including product (pleural drainage systems (traditional pleural drainage systems, digital pleural drainage systems), pleural drainage systems kits, and pleural drainage systems accessories), indication (pleural effusion, hemothorax, spontaneous pneumothorax, tension pneumothorax, traumatic pneumothorax, cardiac tamponade, coronary artery bypass grafting (CABG) procedures, open heart surgeries), and end-user (hospitals, specialty clinics, and ambulatory surgical centers) across ten key regions.
Request to obtain a detailed research methodology of the Chest Drainage systems market: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7121
Chest Drainage System Market Report Scope
| Attribute | Details | |
| Estimated Market Value (2023) | US$ 1,034.25 million | |
| Projected Market Size (2033) | US$ 1,795.93 Million | |
| Expected Growth Rate (2023 to 2033) | 5.7 % | |
| Forecast Period | 2023 to 2033 | |
| Historical Data Available for | 2017 to 2022 | |
| Market Analysis | US$ Million for Value | |
| Key Regions Covered | North America, Latin America, East Asia, South Asia Pacific, Western Europe, Eastern Europe, Central Asia, Russia & Belarus, Balkan & Baltic Countries, Middle East & Africa. | |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Chile, Peru, Colombia, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam, Australia and New Zealand, United Kingdom, Germany, France, Spain, Italy, BENELUX, Nordic Countries, Poland, Hungary, Romania, Czech Republic, GCC Countries, Türkiye, Northern Africa, South Africa, Israel. | |
| Key Market Segments Covered | Product, Indication, End-user, and Region | |
| Key Companies Profiled |
|
|
About Healthcare Division at Future Market Insights (FMI)
Future Market Insights (FMI) facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business. Know more about our sector coverage here.
About the Author:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s Extensive Coverage in Healthcare Domain:
- Global sales of the Surgical Drainage Devices Market in 2021 were held at US$ 1.3 Billion. With a CAGR of 7.7% from 2022 to 2032, the market is projected to reach a valuation of US$ 2.9 Billion by 2032. Active Drainage Devices is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 7.8% from 2022 to 2032.
- The market for pleural disease therapeutics is expected to reach US$ 4.98 billion in 2023 and is estimated to achieve a compounded annual growth rate (CAGR) of 6.5% from 2023 to 2033. It is anticipated that the market will reach US$ 9.4 billion by the end of the forecast period
- By 2033, the global Pigmented Lesion Treatment Market will reach US$ 7,614.7 million. Pigmented lesion treatment providers are forecasting a 7.8% Compound Annual Growth Rate (CAGR) for the market, with its current worth at US$ 3,591.3 million in 2023.
- The global hypercalcemia treatment market is expected to reach US$ 18.07 billion by the end of 2023, with an anticipated compound annual growth rate (CAGR) of 11.8% over the forecast period. If this substantial growth rate is maintained, the market could potentially reach a valuation of US$ 55.07 billion by 2033.
- In 2023, the liposuction surgery devices market is projected to be valued at US$ 2.9 million, compared to its 2022 valuation of US$ 2.7 million. The market is expected to experience strong growth with a compound annual growth rate (CAGR) of 11.6% over the forecast period. By 2033, the market’s estimated valuation is anticipated to reach around US$ 8.9 million.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
View original content:
